Prostaglandin D2 pathway in a transgenic rat model of Alzheimer's disease: therapeutic potential of timapiprant a DP2 antagonist
Charles H. Wallace, Giovanni Oliveros, Peter A. Serrano, Patricia Rockwell, Lei Xie, Maria E. Figueiredo-Pereira
The paper investigates the PGD2 pathway in a transgenic rat model of Alzheimer's disease and shows that timapiprant, a DP2 antagonist, mitigates AD pathology.
bioRxiv · Mar 30, 2022 · PreprintNeuroscience